111 related articles for article (PubMed ID: 20453808)
1. Retinal vein occlusion and low-dose fibrinolytic therapy.
Chhablani J; Babu A; Caraza M
Retina; 2010 May; 30(5):840; author reply 840-2. PubMed ID: 20453808
[No Abstract] [Full Text] [Related]
2. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
3. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
4. Retinal endovascular lysis.
Weiss JN
Ophthalmology; 2008 Jan; 115(1):216-7; author reply 218. PubMed ID: 18166422
[No Abstract] [Full Text] [Related]
5. [Search for retinal vein occlusion and tissue plasminogen activator].
Kadonosono K
Nippon Ganka Gakkai Zasshi; 2009 Apr; 113(4):475-7. PubMed ID: 19455968
[No Abstract] [Full Text] [Related]
6. Intravenous tissue plasminogen activator in central retinal artery occlusion.
Falavarjani KG; Modarres M
Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
[No Abstract] [Full Text] [Related]
7. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion.
Hattenbach LO; Wellermann G; Steinkamp GW; Scharrer I; Koch FH; Ohrloff C
Ophthalmologica; 1999; 213(6):360-6. PubMed ID: 10567867
[TBL] [Abstract][Full Text] [Related]
8. [Use of thrombolytic agents during invasive treatments for retinal vascular occlusions].
Sosnovskiĭ VV; Sdobnikova SV
Vestn Oftalmol; 2007; 123(5):51-4. PubMed ID: 18078061
[No Abstract] [Full Text] [Related]
9. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
10. Histopathological findings after retinal endovascular lysis in central retinal vein occlusion.
Feltgen N; Agostini H; Auw-Haedrich C; Hansen LL
Br J Ophthalmol; 2007 Apr; 91(4):558-9. PubMed ID: 17372342
[No Abstract] [Full Text] [Related]
11. Tissue plasminogen activator can effectively declot peritoneal dialysis catheters.
Sahani MM; Mukhtar KN; Boorgu R; Leehey DJ; Popli S; Ing TS
Am J Kidney Dis; 2000 Sep; 36(3):675. PubMed ID: 10977805
[No Abstract] [Full Text] [Related]
12. [Local intra-arterial fibrinolysis in a single-eyed patient with acute occlusion of the central retinal artery].
Bonnin N; Thomas V; Gabrillargues J; Bacin F
J Fr Ophtalmol; 2009 Jun; 32(6):415-9. PubMed ID: 19515456
[TBL] [Abstract][Full Text] [Related]
13. [Experiment study of infusing tPA in retinal vein for treatment of retinal vein occlusion].
Hu YT; Ma ZZ; Zhang XL; Han SY; Huang LJ
Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):645-9. PubMed ID: 14766057
[TBL] [Abstract][Full Text] [Related]
14. [Systemic lysis therapy in retinal vascular occlusions].
Hattenbach LO
Ophthalmologe; 1998 Aug; 95(8):568-75. PubMed ID: 9782735
[TBL] [Abstract][Full Text] [Related]
15. [Front-loading rt PA thrombolytic therapy in central or venous branch occlusions of the retina].
Steinkamp GW; Hattenbach LO; Scharrer I; Ohrloff C
Ophthalmologe; 1994 Jun; 91(3):280-2. PubMed ID: 8086742
[TBL] [Abstract][Full Text] [Related]
16. Post-vitrectomy tissue plasminogen activator injection for central retinal vein occlusion.
Christodoulakis EV; Tsilimbaris MK
Ophthalmic Surg Lasers Imaging; 2008; 39(3):252-6. PubMed ID: 18556955
[TBL] [Abstract][Full Text] [Related]
17. [Quicker thrombolytic treatment in stroke?].
Johnsen SH
Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2213. PubMed ID: 19898566
[No Abstract] [Full Text] [Related]
18. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
19. Experimental endoscopic endovascular cannulation: a novel approach to thrombolysis in retinal vessel occlusion.
Hattenbach LO; Puchta J; Hilgenberg I
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):42-6. PubMed ID: 22131392
[TBL] [Abstract][Full Text] [Related]
20. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
Sharma VK; Teoh HL; Chan BP
J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
